1. Home
  2. LASE vs ELTX Comparison

LASE vs ELTX Comparison

Compare LASE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Laser Photonics Corporation

LASE

Laser Photonics Corporation

HOLD

Current Price

$0.41

Market Cap

46.2M

Sector

Industrials

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

SELL

Current Price

$1.45

Market Cap

45.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LASE
ELTX
Founded
2019
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.2M
45.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
LASE
ELTX
Price
$0.41
$1.45
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
★ 1.1M
310.7K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
★ N/A
N/A
Revenue
$721,185.00
★ $2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$89.93
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.38
$1.25
52 Week High
$4.49
$16.00

Technical Indicators

Market Signals
Indicator
LASE
ELTX
Relative Strength Index (RSI) 29.27 40.73
Support Level N/A $1.44
Resistance Level $0.79 $1.98
Average True Range (ATR) 0.06 0.19
MACD -0.01 0.01
Stochastic Oscillator 8.10 38.47

Price Performance

Historical Comparison
LASE
ELTX

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasive blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, machine manufacturing, nuclear maintenance and decommissioning, and surface coating. Geographically, the company generates almost all of its revenue from the domestic region.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: